Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001246 · ClinicalTrials.gov registry record
Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers
A clinical trial of Schizophrenia and Attention Deficit Hyperactivity Disorder, sponsored by National Institute of Mental Health (NIMH).
- Active
- Registry status
- 4,274
- Enrollment target
- 1
- Study location
NCT00001246 is a study of Schizophrenia and Attention Deficit Hyperactivity Disorder that is active but no longer recruiting, run by National Institute of Mental Health (NIMH). The registered enrollment target is 4,274 participants, above the 205-participant average among 315 other Schizophrenia trials with a reported enrollment target (1985% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00001246, a study of Schizophrenia and Attention Deficit Hyperactivity Disorder, is active but no longer recruiting, sponsored by National Institute of Mental Health (NIMH).
- ACTIVE NOT RECRUITING
- Registry status
- 4,274 participants
- Enrollment target
- 1
- Study location
Study Summary
Magnetic Resonance Imaging (MRI) unlike X-rays and CT-scans does not use radiation to create a picture. MRI use as the name implies, magnetism to create pictures with excellent anatomical resolution. Functional MRIs are diagnostic tests that allow doctors to not only view anatomy, but physiology and function. It is for these reasons that MRIs are excellent methods for studying the brain. In this study, researchers will use MRI to assess brain anatomy and function in X and Y chromosome variation, healthy volunteers, and patients with a variety of childhood onset psychiatric disorders. The disorders include attention deficit disorder, autism, congenital adrenal hyperplasia, childhood-onset schizophrenia, dyslexia, obsessive compulsive disorder, Sydenham's chorea, and Tourette's syndrome. Results of the MRIs showing the anatomy of the brain and brain function will be compared across age, sex (gender), and diagnostic groups. Correlations between brain and behavioral measures will be examined for normal and clinical populations.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,274 participants |
| Start Date | 1990-06-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001246
The ClinicalTrials.gov registry entry for NCT00001246 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 4,274 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 205-participant average among 315 other Schizophrenia trials with a reported enrollment target (1985% higher). The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Schizophrenia appearing as the primary indexed condition, and to 0 interventions.
NCT00001246 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00001246 about?
NCT00001246 is a clinical study titled "Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers". Magnetic Resonance Imaging (MRI) unlike X-rays and CT-scans does not use radiation to create a picture. MRI use as the name implies, magnetism to create pictures with excellent anatomical resolution. Functional MRIs are diagnostic tests that allow doctors to not only view anatomy, but physiology and...
What is the current status of trial NCT00001246?
This trial is currently active not recruiting. The enrollment target is 4,274 participants. The study started on 1990-06-19.
What conditions does trial NCT00001246 study?
This clinical trial studies the following conditions: Schizophrenia, Attention Deficit Hyperactivity Disorder, Attention Deficit Disorder With Hyperactivity.
Who is sponsoring clinical trial NCT00001246?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001246 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
Tolerability of MDMA in Schizophrenia
RECRUITING · Phase 1
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
RECRUITING · Phase 4
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.